Logo image of NUWE

NUWELLIS INC (NUWE) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:NUWE - US67113Y7022 - Common Stock

1.9 USD
-0.47 (-19.83%)
Last: 1/16/2026, 8:00:01 PM
1.86 USD
-0.04 (-2.11%)
After Hours: 1/16/2026, 8:00:01 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to NUWE. NUWE was compared to 185 industry peers in the Health Care Equipment & Supplies industry. While NUWE seems to be doing ok healthwise, there are quite some concerns on its profitability. NUWE is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year NUWE has reported negative net income.
  • In the past year NUWE has reported a negative cash flow from operations.
  • In the past 5 years NUWE always reported negative net income.
  • In the past 5 years NUWE always reported negative operating cash flow.
NUWE Yearly Net Income VS EBIT VS OCF VS FCFNUWE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -207.46%, NUWE is doing worse than 90.81% of the companies in the same industry.
  • NUWE has a worse Return On Equity (-423.19%) than 80.54% of its industry peers.
Industry RankSector Rank
ROA -207.46%
ROE -423.19%
ROIC N/A
ROA(3y)-132.73%
ROA(5y)-110.12%
ROE(3y)-328.31%
ROE(5y)-233.66%
ROIC(3y)N/A
ROIC(5y)N/A
NUWE Yearly ROA, ROE, ROICNUWE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600 -800 -1K

1.3 Margins

  • NUWE has a Gross Margin of 59.07%. This is comparable to the rest of the industry: NUWE outperforms 58.92% of its industry peers.
  • NUWE's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for NUWE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 59.07%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.63%
GM growth 5Y4.66%
NUWE Yearly Profit, Operating, Gross MarginsNUWE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

More info and screens

5

2. Health

2.1 Basic Checks

  • NUWE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • NUWE has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, NUWE has more shares outstanding
  • There is no outstanding debt for NUWE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NUWE Yearly Shares OutstandingNUWE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20K 40K 60K 80K 100K
NUWE Yearly Total Debt VS Total AssetsNUWE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • NUWE has an Altman-Z score of -57.45. This is a bad value and indicates that NUWE is not financially healthy and even has some risk of bankruptcy.
  • NUWE has a Altman-Z score of -57.45. This is amonst the worse of the industry: NUWE underperforms 92.43% of its industry peers.
  • NUWE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -57.45
ROIC/WACCN/A
WACC10%
NUWE Yearly LT Debt VS Equity VS FCFNUWE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

  • A Current Ratio of 2.04 indicates that NUWE has no problem at all paying its short term obligations.
  • With a Current ratio value of 2.04, NUWE is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
  • A Quick Ratio of 1.42 indicates that NUWE should not have too much problems paying its short term obligations.
  • NUWE has a Quick ratio (1.42) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.04
Quick Ratio 1.42
NUWE Yearly Current Assets VS Current LiabilitesNUWE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 91.32% over the past year.
  • NUWE shows a decrease in Revenue. In the last year, the revenue decreased by -8.93%.
  • The Revenue has been growing by 9.67% on average over the past years. This is quite good.
EPS 1Y (TTM)91.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-99.23%
Revenue 1Y (TTM)-8.93%
Revenue growth 3Y3.34%
Revenue growth 5Y9.67%
Sales Q2Q%-6.34%

3.2 Future

  • NUWE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.98% yearly.
  • Based on estimates for the next years, NUWE will show a very strong growth in Revenue. The Revenue will grow by 45.06% on average per year.
EPS Next Y98.39%
EPS Next 2Y41.38%
EPS Next 3Y25.98%
EPS Next 5YN/A
Revenue Next Year-8.15%
Revenue Next 2Y0.74%
Revenue Next 3Y6.34%
Revenue Next 5Y45.06%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NUWE Yearly Revenue VS EstimatesNUWE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 20M 40M 60M 80M
NUWE Yearly EPS VS EstimatesNUWE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -10B -20B -30B -40B -50B

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NUWE. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NUWE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NUWE Price Earnings VS Forward Price EarningsNUWE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NUWE Per share dataNUWE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -500 -1K -1.5K

4.3 Compensation for Growth

  • A more expensive valuation may be justified as NUWE's earnings are expected to grow with 25.98% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.38%
EPS Next 3Y25.98%

More info and screens

0

5. Dividend

5.1 Amount

  • NUWE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

NUWELLIS INC

NASDAQ:NUWE (1/16/2026, 8:00:01 PM)

After market: 1.86 -0.04 (-2.11%)

1.9

-0.47 (-19.83%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-12
Earnings (Next)03-09
Inst Owners5.05%
Inst Owner Change0%
Ins Owners0.02%
Ins Owner Change0%
Market Cap3.15M
Revenue(TTM)8.17M
Net Income(TTM)-16.56M
Analysts43.33
Price TargetN/A
Short Float %0.52%
Short Ratio0.11
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-18.09%
Min Revenue beat(2)-23.13%
Max Revenue beat(2)-13.06%
Revenue beat(4)0
Avg Revenue beat(4)-15.38%
Min Revenue beat(4)-23.13%
Max Revenue beat(4)-7.53%
Revenue beat(8)1
Avg Revenue beat(8)-8.34%
Revenue beat(12)3
Avg Revenue beat(12)-7.48%
Revenue beat(16)5
Avg Revenue beat(16)-7.29%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-457.14%
EPS NY rev (1m)0%
EPS NY rev (3m)-1232.64%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-20.78%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-10.65%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.39
P/FCF N/A
P/OCF N/A
P/B 0.81
P/tB 0.81
EV/EBITDA N/A
EPS(TTM)-1630.02
EYN/A
EPS(NY)-1.91
Fwd EYN/A
FCF(TTM)-5.67
FCFYN/A
OCF(TTM)-5.59
OCFYN/A
SpS4.92
BVpS2.36
TBVpS2.36
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -207.46%
ROE -423.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 59.07%
FCFM N/A
ROA(3y)-132.73%
ROA(5y)-110.12%
ROE(3y)-328.31%
ROE(5y)-233.66%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.63%
GM growth 5Y4.66%
F-Score4
Asset Turnover1.02
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 50.2%
Cap/Sales 1.53%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.04
Quick Ratio 1.42
Altman-Z -57.45
F-Score4
WACC10%
ROIC/WACCN/A
Cap/Depr(3y)40.1%
Cap/Depr(5y)48.83%
Cap/Sales(3y)1.63%
Cap/Sales(5y)2.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)91.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-99.23%
EPS Next Y98.39%
EPS Next 2Y41.38%
EPS Next 3Y25.98%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.93%
Revenue growth 3Y3.34%
Revenue growth 5Y9.67%
Sales Q2Q%-6.34%
Revenue Next Year-8.15%
Revenue Next 2Y0.74%
Revenue Next 3Y6.34%
Revenue Next 5Y45.06%
EBIT growth 1Y9.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y49.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y49.3%
OCF growth 3YN/A
OCF growth 5YN/A

NUWELLIS INC / NUWE FAQ

Can you provide the ChartMill fundamental rating for NUWELLIS INC?

ChartMill assigns a fundamental rating of 3 / 10 to NUWE.


Can you provide the valuation status for NUWELLIS INC?

ChartMill assigns a valuation rating of 1 / 10 to NUWELLIS INC (NUWE). This can be considered as Overvalued.


What is the profitability of NUWE stock?

NUWELLIS INC (NUWE) has a profitability rating of 1 / 10.


What is the financial health of NUWELLIS INC (NUWE) stock?

The financial health rating of NUWELLIS INC (NUWE) is 5 / 10.